{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T17:22:39Z","timestamp":1784568159895,"version":"3.55.0"},"reference-count":83,"publisher":"Georg Thieme Verlag KG","issue":"03","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Thromb Hemost"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Patients with cancer have an increased risk of venous thromboembolism (VTE). Comparing tumor-specific VTE risk is complicated by factors such as surgery, disease stage, and chemotherapy. Network meta-analysis (NMA) using cancer types as network nodes enabled us to estimate VTE rates by leveraging comparisons across cancer types while adjusting for baseline VTE risk in individual studies. This study was conducted to estimate the risk of VTE by cancer type and factors influencing VTE risk. The Embase, MEDLINE, and Cochrane Library repositories were systematically searched to identify clinical trials and observational studies published from 2005 to 2022 that assessed the risk of primary cancer-related VTE among two or more distinct cancer types. Studies with similar cancer populations and study methods reporting VTE occurring within 1 year of diagnosis were included in the NMA. Relative VTE rates across cancer types were estimated with random-effects Bayesian NMAs. Absolute VTE rates were calculated from these estimates using the average VTE incidence in lung cancer (the most frequently reported type) as the \u201canchor.\u201d From 2,603 records reviewed, 30 studies were included in this NMA. The general network described 3,948,752 patients and 18 cancer types: 3.1% experienced VTE within 1 year of diagnosis, with cancer-specific rates ranging from 0.7 to 7.4%. Consistent with existing VTE risk prediction tools, pancreatic cancer was associated with higher-than-average VTE risk. Other cancer types with high VTE risk were brain and ovarian cancers. The relative rankings of VTE risk for certain cancers changed based on disease stage and\/or receipt of chemotherapy or surgery.<\/jats:p>","DOI":"10.1055\/s-0044-1779672","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T23:57:11Z","timestamp":1708732631000},"page":"328-341","source":"Crossref","is-referenced-by-count":21,"title":["Risk of Venous Thromboembolism by Cancer Type: A Network Meta-Analysis"],"prefix":"10.1055","volume":"50","author":[{"given":"Marissa B.","family":"Betts","sequence":"additional","affiliation":[{"name":"Evidera, Waltham, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejun","family":"Liu","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb Company, Lawrenceville, New Jersey"},{"name":"Department of Health Policy and Management, Gillings School of Public Health, UNC-Chapel Hill, Chapel Hill, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela R.","family":"Junqueira","sequence":"additional","affiliation":[{"name":"Evidera, Waltham, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Fahrbach","sequence":"additional","affiliation":[{"name":"Evidera, Waltham, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binod","family":"Neupane","sequence":"additional","affiliation":[{"name":"Evidera, Waltham, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Ronnebaum","sequence":"additional","affiliation":[{"name":"Evidera, Waltham, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amol D.","family":"Dhamane","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb Company, Lawrenceville, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,2,23]]},"reference":[{"issue":"06","key":"ref1","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3324\/haematol.2018.209114","article-title":"The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis","volume":"104","author":"F I Mulder","year":"2019","journal-title":"Haematologica"},{"issue":"S 01","key":"ref2","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/j.thromres.2018.01.028","article-title":"Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer","volume":"164","author":"G H Lyman","year":"2018","journal-title":"Thromb Res"},{"issue":"06","key":"ref3","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archinte.160.6.809","article-title":"Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study","volume":"160","author":"J A Heit","year":"2000","journal-title":"Arch Intern Med"},{"issue":"06","key":"ref4","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.ejca.2012.10.021","article-title":"Incidence of venous thromboembolism in patients with cancer - a cohort study using linked United Kingdom databases","volume":"49","author":"A J Walker","year":"2013","journal-title":"Eur J Cancer"},{"issue":"02","key":"ref5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11239-020-02180-x","article-title":"Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE","volume":"50","author":"J I Weitz","year":"2020","journal-title":"J Thromb Thrombolysis"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3390\/cancers10100380","article-title":"Cancer-associated thrombosis: an overview of mechanisms, risk factors, and treatment","volume":"10","author":"N B Abdol Razak","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1160\/TH16-08-0615","article-title":"Cancer-associated venous thromboembolism: burden, mechanisms, and management","volume":"117","author":"C Ay","year":"2017","journal-title":"Thromb Haemost"},{"issue":"07","key":"ref8","doi-asserted-by":"crossref","first-page":"e1001275","DOI":"10.1371\/journal.pmed.1001275","article-title":"Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis","volume":"9","author":"F Horsted","year":"2012","journal-title":"PLoS Med"},{"issue":"05","key":"ref9","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO Clinical Practice Guideline Update","volume":"38","author":"N S Key","year":"2020","journal-title":"J Clin Oncol"},{"issue":"07","key":"ref10","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/S1470-2045(22)00160-7","article-title":"2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19","volume":"23","author":"D Farge","year":"2022","journal-title":"Lancet Oncol"},{"issue":"13","key":"ref11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.6004\/jnccn.2021.7108","article-title":"Update on guidelines for the prevention of cancer-associated thrombosis","volume":"20","author":"A Elshoury","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"issue":"10","key":"ref12","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1182\/bloodadvances.2021006484","article-title":"Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy","volume":"6","author":"T F Overvad","year":"2022","journal-title":"Blood Adv"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","article-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis","volume":"111","author":"A A Khorana","year":"2008","journal-title":"Blood"},{"issue":"24","key":"ref14","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1182\/blood-2010-02-270116","article-title":"Prediction of venous thromboembolism in cancer patients","volume":"116","author":"C Ay","year":"2010","journal-title":"Blood"},{"issue":"01","key":"ref15","doi-asserted-by":"crossref","first-page":"e12634","DOI":"10.1002\/rth2.12634","article-title":"Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myeloma","volume":"6","author":"K M Sanfilippo","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"issue":"03","key":"ref16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11739-012-0784-y","article-title":"A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the PROTECHT score","volume":"7","author":"M Verso","year":"2012","journal-title":"Intern Emerg Med"},{"issue":"09","key":"ref17","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.3324\/haematol.2017.169060","article-title":"Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study","volume":"102","author":"N van Es","year":"2017","journal-title":"Haematologica"},{"issue":"12","key":"ref18","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1111\/jth.15503","article-title":"Evaluation of the Khorana, PROTECHT, and 5-SNP scores for prediction of venous thromboembolism in patients with cancer","volume":"19","author":"N AM Guman","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref19","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1002\/onco.13569","article-title":"Prediction and prevention of cancer-associated thromboembolism","volume":"26","author":"A A Khorana","year":"2021","journal-title":"Oncologist"},{"issue":"05","key":"ref20","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1634\/theoncologist.2016-0246","article-title":"Preventing venous thromboembolism in ambulatory cancer patients: the ONKOTEV study","volume":"22","author":"C A Cella","year":"2017","journal-title":"Oncologist"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1634\/theoncologist.2016-0414","article-title":"A predictive score for thrombosis associated with breast, colorectal, lung, or ovarian cancer: the prospective COMPASS-Cancer-Associated Thrombosis Study","volume":"22","author":"G T Gerotziafas","year":"2017","journal-title":"Oncologist"},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1111\/jth.14614","article-title":"Risk factors for cancer-associated venous thromboembolism: the venous thromboembolism prevention in the ambulatory cancer clinic (VTE-PACC) study","volume":"17","author":"D R Douce","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1160\/TH15-08-0686","article-title":"Epidemiology of first and recurrent venous thromboembolism in patients with active cancer: a population-based cohort study","volume":"117","author":"A T Cohen","year":"2017","journal-title":"Thromb Haemost"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.thromres.2015.11.033","article-title":"The economic burden of incident venous thromboembolism in the United States: a review of estimated attributable healthcare costs","volume":"137","author":"S D Grosse","year":"2016","journal-title":"Thromb Res"},{"issue":"11","key":"ref25","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1080\/13696998.2019.1620752","article-title":"Healthcare resource utilization and costs associated with venous thromboembolism in cancer patients treated with anticoagulants","volume":"22","author":"M Streiff","year":"2019","journal-title":"J Med Econ"},{"issue":"04","key":"ref26","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/13696998.2019.1703190","article-title":"Healthcare resource utilization and costs associated with venous thromboembolism recurrence in patients with cancer","volume":"23","author":"A A Khorana","year":"2020","journal-title":"J Med Econ"},{"issue":"03","key":"ref27","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1538-7836.2006.01804.x","article-title":"Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study","volume":"4","author":"J W Blom","year":"2006","journal-title":"J Thromb Haemost"},{"key":"ref28","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020)","author":"J PT Higgins","year":"2020"},{"issue":"71","key":"ref29","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"M J Page","year":"2021","journal-title":"BMJ"},{"issue":"06","key":"ref30","first-page":"262","article-title":"The PRISMA statement extension for systematic reviews incorporating network meta-analysis: PRISMA-NMA [in Spanish]","volume":"147","author":"B Hutton","year":"2016","journal-title":"Med Cl\u00edn (Barc)"},{"issue":"04","key":"ref33","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/10618600.1998.10474787","article-title":"General methods for monitoring convergence of iterative simulations","volume":"7","author":"S P Brooks","year":"1998","journal-title":"J Comput Graph Stat"},{"key":"ref34","first-page":"131","volume-title":"Inference and monitoring convergence","author":"A Gelman","year":"1996"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","article-title":"Ranking treatments in frequentist network meta-analysis works without resampling methods","volume":"15","author":"G R\u00fccker","year":"2015","journal-title":"BMC Med Res Methodol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"J P Higgins","year":"2003","journal-title":"BMJ"},{"issue":"02","key":"ref37","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/jth.13587","article-title":"Recurrence and mortality after first venous thromboembolism in a large population-based cohort","volume":"15","author":"N Arshad","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref38","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1186\/s12885-020-06930-1","article-title":"Could venous thromboembolism and major bleeding be indicators of lung cancer mortality? A nationwide database study","volume":"20","author":"J Howlett","year":"2020","journal-title":"BMC Cancer"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jfma.2021.04.025","article-title":"Incidence and risk factors for venous thromboembolism in a cohort of Taiwanese patients with lung, gastric, pancreatic cancers or lymphoma","volume":"121","author":"S C Chou","year":"2022","journal-title":"J Formos Med Assoc"},{"key":"ref40","first-page":"182521","article-title":"Predictors of venous thromboembolism in patients with advanced common solid cancers","volume":"2009","author":"I E Hall","year":"2009","journal-title":"J Cancer Epidemiol"},{"issue":"10","key":"ref41","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1002\/cncr.23062","article-title":"Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients","volume":"110","author":"A A Khorana","year":"2007","journal-title":"Cancer"},{"issue":"01","key":"ref42","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/bloodadvances.2021005590","article-title":"The incidence of cancer-associated thrombosis is increasing over time","volume":"6","author":"A Mahajan","year":"2022","journal-title":"Blood Adv"},{"issue":"11","key":"ref43","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1093\/jjco\/hyaa112","article-title":"Venous thromboembolism in cancer patients: report of baseline data from the multicentre, prospective Cancer-VTE Registry","volume":"50","author":"Y Ohashi","year":"2020","journal-title":"Jpn J Clin Oncol"},{"issue":"01","key":"ref44","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.amjmed.2005.06.058","article-title":"Incidence of venous thromboembolism in patients hospitalized with cancer","volume":"119","author":"P D Stein","year":"2006","journal-title":"Am J Med"},{"issue":"08","key":"ref45","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1111\/jth.14824","article-title":"The Khorana score for prediction of venous thromboembolism in cancer patients: an individual patient data meta-analysis","volume":"18","author":"N van Es","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"151","key":"ref46","doi-asserted-by":"crossref","first-page":"180119","DOI":"10.1183\/16000617.0119-2018","article-title":"Cancer-associated thrombosis: the when, how and why","volume":"28","author":"C J Fernandes","year":"2019","journal-title":"Eur Respir Rev"},{"issue":"04","key":"ref47","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer","volume":"5","author":"G H Lyman","year":"2021","journal-title":"Blood Adv"},{"issue":"06","key":"ref48","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/pbc.21734","article-title":"Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer","volume":"51","author":"U Athale","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.thromres.2021.01.014","article-title":"Incidence and risk factors of venous thrombotic events in pediatric patients with CNS tumors compared with non-CNS cancer: a population-based cohort study","volume":"200","author":"C Howie","year":"2021","journal-title":"Thromb Res"},{"issue":"02","key":"ref50","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.thromres.2011.03.014","article-title":"Epidemiology of venous thromboembolism in children with malignant diseases: a single-center study of the Belarusian Center for Pediatric Oncology and Hematology","volume":"128","author":"N V Lipay","year":"2011","journal-title":"Thromb Res"},{"issue":"07","key":"ref51","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1016\/S2352-3026(18)30063-2","article-title":"A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts","volume":"5","author":"I Pabinger","year":"2018","journal-title":"Lancet Haematol"},{"issue":"07","key":"ref52","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/jth.14149","article-title":"Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis","volume":"16","author":"M Di Nisio","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"04","key":"ref53","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4310\/SII.2020.v13.n4.a1","article-title":"On evidence cycles in network meta-analysis","volume":"13","author":"L Lin","year":"2020","journal-title":"Stat Interface"},{"issue":"01","key":"ref54","doi-asserted-by":"crossref","first-page":"e000788","DOI":"10.1136\/openhrt-2018-000788","article-title":"Strengths and weaknesses of \u2018real-world\u2019 studies involving non-vitamin K antagonist oral anticoagulants","volume":"5","author":"A J Camm","year":"2018","journal-title":"Open Heart"},{"issue":"03","key":"ref55","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4103\/picr.picr_62_21","article-title":"Introduction to real-world evidence studies","volume":"12","author":"D Chodankar","year":"2021","journal-title":"Perspect Clin Res"},{"issue":"01","key":"ref56","doi-asserted-by":"crossref","first-page":"100057","DOI":"10.1016\/j.rpth.2023.100057","article-title":"Treatment and prevention of cancer-associated thrombosis in the Netherlands: a national survey","volume":"7","author":"F HJ Kaptein","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"issue":"05","key":"ref57","first-page":"255","article-title":"Prevention and treatment of cancer-associated thrombosis in France: a national survey among vascular disease and supportive care specialists","volume":"42","author":"I Mah\u00e9","year":"2017","journal-title":"J Med Vasc"},{"issue":"07","key":"ref58","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/rth2.12431","article-title":"Preventing venous thromboembolism in oncology practice: use of risk assessment and anticoagulation prophylaxis","volume":"4","author":"K A Martin","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"issue":"04","key":"ref59","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11739-016-1578-4","article-title":"Prevention and treatment of venous thromboembolism in patients with solid brain neoplasms: results of a survey among Italian physicians","volume":"12","author":"N Mumoli","year":"2017","journal-title":"Intern Emerg Med"},{"issue":"01","key":"ref60","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/imj.15984","article-title":"Survey of medical oncologists and trainee practice on venous thromboembolism prophylaxis and treatment in solid cancers","volume":"53","author":"J Yeung","year":"2023","journal-title":"Intern Med J"},{"issue":"02","key":"ref61","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/COC.0000000000000639","article-title":"Black patients experience highest rates of cancer-associated venous thromboembolism","volume":"43","author":"N O Addo-Tabiri","year":"2020","journal-title":"Am J Clin Oncol"},{"issue":"01","key":"ref62","doi-asserted-by":"crossref","first-page":"17","DOI":"10.14740\/jh471","article-title":"Retrospective cohort study of venous thromboembolism rates in ambulatory cancer patients: association with Khorana score and other risk factors","volume":"8","author":"K Austin","year":"2019","journal-title":"J Hematol (Brossard)"},{"issue":"07","key":"ref63","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/jth.14130","article-title":"Impact of time since diagnosis and mortality rate on cancer-associated venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) cohort","volume":"16","author":"K Blix","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"07","key":"ref64","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/sj.bjc.6605883","article-title":"Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006","volume":"103","author":"D P Cronin-Fenton","year":"2010","journal-title":"Br J Cancer"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.thromres.2017.09.002","article-title":"Epidemiology of venous thromboembolism in hematological cancers: the Scandinavian Thrombosis and Cancer (STAC) cohort","volume":"158","author":"I L Gade","year":"2017","journal-title":"Thromb Res"},{"issue":"03","key":"ref66","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s12185-021-03167-x","article-title":"Incidence of venous thromboembolism in patients with solid cancers in Japan: retrospective study of 2735 patients","volume":"114","author":"T Nose","year":"2021","journal-title":"Int J Hematol"},{"issue":"07","key":"ref67","doi-asserted-by":"crossref","first-page":"e1083","DOI":"10.1634\/theoncologist.2019-0482","article-title":"External validation of a venous thromboembolic risk score for cancer outpatients with solid tumors: the COMPASS-CAT Venous Thromboembolism Risk Assessment Model","volume":"25","author":"A C Spyropoulos","year":"2020","journal-title":"Oncologist"},{"issue":"08","key":"ref68","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/jth.13752","article-title":"The impact of initial cancer stage on the incidence of venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) Cohort","volume":"15","author":"I L Gade","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref69","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13045-016-0291-0","article-title":"Risk of venous thromboembolism in hospitalised cancer patients in England-a cohort study","volume":"9","author":"S Ratib","year":"2016","journal-title":"J Hematol Oncol"},{"issue":"12","key":"ref70","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1002\/cncr.21496","article-title":"Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study","volume":"104","author":"A A Khorana","year":"2005","journal-title":"Cancer"},{"issue":"03","key":"ref71","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/cncr.27772","article-title":"Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States","volume":"119","author":"A A Khorana","year":"2013","journal-title":"Cancer"},{"issue":"12","key":"ref72","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1634\/theoncologist.2013-0226","article-title":"Venous thromboembolism risk in patients with cancer receiving chemotherapy: a real-world analysis","volume":"18","author":"G H Lyman","year":"2013","journal-title":"Oncologist"},{"issue":"04","key":"ref73","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/annonc\/mdp354","article-title":"Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial","volume":"21","author":"M Mandal\u00e0","year":"2010","journal-title":"Ann Oncol"},{"issue":"06","key":"ref74","doi-asserted-by":"crossref","first-page":"doz079","DOI":"10.1093\/dote\/doz079","article-title":"The risk of venous thromboembolism after surgery for esophagogastric malignancy and the impact of chemotherapy: a population-based cohort study","volume":"33","author":"A Adiamah","year":"2020","journal-title":"Dis Esophagus"},{"issue":"01","key":"ref75","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/01.sla.0000193959.44677.48","article-title":"A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project","volume":"243","author":"G Agnelli","year":"2006","journal-title":"Ann Surg"},{"issue":"05","key":"ref76","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1503\/cjs.012314","article-title":"Diagnosis of VTE postdischarge for major abdominal and pelvic oncologic surgery: implications for a change in practice","volume":"58","author":"H Alsubaie","year":"2015","journal-title":"Can J Surg"},{"issue":"12","key":"ref77","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1245\/s10434-011-1723-2","article-title":"Rates of venous thromboembolism among patients with major surgery for cancer","volume":"18","author":"J Hammond","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"03","key":"ref78","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/jso.25832","article-title":"Minimally invasive cancer surgery is associated with a lower risk of venous thromboembolic events","volume":"121","author":"M J Krimphove","year":"2020","journal-title":"J Surg Oncol"},{"issue":"04","key":"ref79","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1001\/jamasurg.2021.7126","article-title":"Readmissions from venous thromboembolism after complex cancer surgery","volume":"157","author":"S Mallick","year":"2022","journal-title":"JAMA Surg"},{"issue":"01","key":"ref80","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/SLA.0b013e31821b98da","article-title":"Post-discharge venous thromboembolism after cancer surgery: extending the case for extended prophylaxis","volume":"254","author":"R P Merkow","year":"2011","journal-title":"Ann Surg"},{"issue":"01","key":"ref81","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ygyno.2010.11.038","article-title":"Incidence and timing of venous thromboembolism after surgery for gynecological cancer","volume":"121","author":"A Peedicayil","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"02","key":"ref82","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s11239-018-1774-3","article-title":"Venous thromboembolism in patients with cancer undergoing surgical exploration","volume":"47","author":"S M Ruff","year":"2019","journal-title":"J Thromb Thrombolysis"},{"issue":"03","key":"ref83","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ygyno.2016.03.023","article-title":"Prescription of extended-duration thromboprophylaxis after high-risk, abdominopelvic cancer surgery","volume":"141","author":"J D Wright","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"15","key":"ref84","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1182\/blood.2020007488","article-title":"Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors","volume":"137","author":"A Dunbar","year":"2021","journal-title":"Blood"},{"issue":"08","key":"ref85","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/j.1538-7836.2010.03948.x","article-title":"Risk factors for developing a new venous thromboembolism in ambulatory patients with non-hematologic malignancies and impact on survival for gastroesophageal malignancies","volume":"8","author":"M A Shah","year":"2010","journal-title":"J Thromb Haemost"}],"container-title":["Seminars in Thrombosis and Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1779672.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T11:55:31Z","timestamp":1730807731000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0044-1779672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,23]]},"references-count":83,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2024,3,8]]},"published-print":{"date-parts":[[2024,4]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0044-1779672","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0094-6176","1098-9064"],"issn-type":[{"value":"0094-6176","type":"print"},{"value":"1098-9064","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,23]]}}}